AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Healthcare
Could Abeona Therapeutics Reshape Gene Therapy Innovation?
March 10, 2025 05:26 PM AEDT| By Team Kalkine MediaHighlight:,Abeona Therapeutics Inc (NASDAQ:ABEO) is set to release its quarterly earnings ahead of market open.,The company is focused on developing gene therapy solutions for rare and severe genetic conditions.,Market observations reveal mixed persp...
Could Jazz Pharmaceuticals Be Redefining Specialty Pharma?
March 10, 2025 05:23 PM AEDT| By Team Kalkine MediaHighlights,Several financial institutions have revised their outlook for the firm.,The firm’s diversified pharmaceutical portfolio addresses a range of global medical needs.,Robust institutional participation underscores widespread market engagement....
Will Concord and SBC Redefine Medical Service Excellence?
March 10, 2025 05:23 PM AEDT| By Team Kalkine MediaHighlights:,SBC Medical Group achieved higher earnings despite lower revenue.,Concord Medical Services operates in China with advanced diagnostic and radiotherapy services.,Both companies enjoy significant backing from large investors.,The medical se...
A Comparative Analysis of Embecta (NASDAQ:EMBC) and Lucid Diagnostics (NASDAQ:LUCD)
March 10, 2025 04:21 PM AEDT| By Team Kalkine MediaHighlights,Lucid Diagnostics holds a superior consensus rating and a potential market upside of 160.79%, positioning it as a promising entity in terms of future growth expectations.,Embecta benefits from strong institutional ownership with 93.8% of i...
Is the Biopharma Landscape Shifting?
March 10, 2025 04:21 PM AEDT| By Team Kalkine MediaHighlights,DBV specializes in epicutaneous immunotherapy for allergy treatments, while Silexion pioneers RNA interference-based cancer therapies.,DBV displays significant institutional support, contrasting with a distinct ownership profile at Silexio...
Can These Small-Cap Biotechs Transform the Sector?
March 10, 2025 04:21 PM AEDT| By Team Kalkine MediaHighlights,Valuation & Earnings Contrast: Agenus Inc. (NASDAQ:AGEN) displays revenue while Cortexyme Inc. (NASDAQ:CRTX) records superior earnings.,Ownership Structure: Cortexyme Inc. (NASDAQ:CRTX) exhibits a greater concentration of management-held s...
Which Pharma Leader Excels in Earnings and Valuation?
March 10, 2025 04:21 PM AEDT| By Team Kalkine MediaHighlights,Teva Pharmaceutical Industries (NYSE:TEVA) exhibits significant institutional investment and maintains a steady share performance.,Avidity Biosciences (NASDAQ:RNA) demonstrates robust earnings in relation to its revenue, while Teva sustain...
Can Small-Cap Medical Innovators Outperform in Healthcare Innovation?
March 10, 2025 04:21 PM AEDT| By Team Kalkine MediaHighlights,Strong institutional share concentration at Neumora Therapeutics (NASDAQ:NEUM) compared to Cidara Therapeutics (NASDAQ:CIDR).,Neumora Therapeutics (NASDAQ:NEUM) shows greater executive share concentration despite lower current revenues.,No...
Is Institutional Interest in Natera Growing Steadily?
March 09, 2025 09:51 PM AEDT| By Team Kalkine MediaHighlights,Notable increase in institutional stake during recent quarters.,Major investment management groups have reshaped their positions.,Operations in molecular diagnostics continue to show robust financial performance.,Natera, Inc. (NASDAQ:NTRA)...
How Is ResMed (NYSE:RMD) Expanding Its Presence in Respiratory Care and Digital Health?
March 08, 2025 04:45 AM AEDT| By Team Kalkine MediaHighlights,Hedge funds and financial firms have adjusted their positions in ResMed, reflecting institutional activity.,The company reported strong quarterly earnings, exceeding previous expectations.,ResMed continues to expand its presence in the med...
How Is Altimmune (NASDAQ:ALT) Navigating the Biopharmaceutical Industry?
March 08, 2025 03:55 AM AEDT| By Team Kalkine MediaHighlights,Institutional investors have been actively adjusting their holdings in Altimmune, Inc., with several increasing or reducing their positions.,Market activity reflects increased engagement from various financial firms, influencing stock perf...
Is Evolus Inc. (NASDAQ:EOLS) Positioned for Strong Growth in the Aesthetics Industry?
March 08, 2025 03:52 AM AEDT| By Team Kalkine MediaHighlights,Institutional investors have made notable adjustments in their stakes in Evolus Inc. signaling strategic market positioning.,Several major investment firms have significantly increased their holdings in the company, highlighting strong con...
Is Quantum-Si (NASDAQ:QSI) a Key Player in Next-Generation Protein Sequencing?
March 08, 2025 03:45 AM AEDT| By Team Kalkine MediaHighlights,Sanctuary Advisors LLC and other financial entities have expanded their stakes in Quantum-Si.,Quantum-Si’s trading range reflects substantial movement over the past year.,The company is advancing Next Generation Protein Sequencing technolo...
Is Adaptive Biotechnologies (NASDAQ:ADPT) Seeing a Shift in Market Sentiment?
March 08, 2025 03:45 AM AEDT| By Team Kalkine MediaHighlights,Principal Financial Group Inc. significantly increased its stake in Adaptive Biotechnologies, reflecting growing institutional interest.,Several institutional investors adjusted their holdings, expanding their positions in the company.,The...
How Are Market Trends Impacting 4D Molecular Therapeutics (NASDAQ:FDMT)?
March 08, 2025 03:40 AM AEDT| By Team Kalkine MediaHighlights,The New York State Common Retirement Fund adjusted its stake in 4D Molecular Therapeutics, reducing its holdings during the fourth quarter.,Several institutional investors made notable changes in their positions, signaling strategic portfo...
How Is Lantern Pharma (NASDAQ:LTRN) Revolutionizing Drug Discovery?
March 08, 2025 03:27 AM AEDT| By Team Kalkine MediaHighlights,Sanctuary Advisors LLC acquired a notable stake in Lantern Pharma, reflecting increased institutional attention.,Westside Investment Management significantly expanded its holdings, indicating rising confidence in the company.,Lantern Pharm...
How Is Blueprint Medicines (NASDAQ:BPMC) Advancing Its Pipeline in Precision Medicine?
March 08, 2025 03:23 AM AEDT| By Team Kalkine MediaHighlights,Institutional firms have increased their holdings in Blueprint Medicines, contributing to stock ownership shifts.,Recent share transactions by company executives have led to adjustments in ownership distribution.,Blueprint Medicines contin...
Is Biohaven Ltd. (NYSE:BHVN) Sustaining Market Interest with New Drug Developments?
March 08, 2025 03:21 AM AEDT| By Team Kalkine MediaHighlights,Institutional firms have modified their holdings in Biohaven Ltd., contributing to shifts in stock ownership.,Biohaven’s stock performance reflects fluctuations, with market participation continuing to evolve.,The company remains focused o...
How Is Ionis Pharmaceuticals (NASDAQ:IONS) Expanding Its RNA-Targeted Therapeutics Portfolio?
March 08, 2025 03:18 AM AEDT| By Team Kalkine MediaHighlights,Institutional firms have adjusted their positions in Ionis Pharmaceuticals, contributing to changes in stock ownership distribution.,Key figures within the company have modified their holdings, reflecting shifts in ownership dynamics.,Mark...
Is Varex Imaging (NASDAQ:VREX) Seeing Increased Institutional Engagement and Market Activity?
March 08, 2025 03:15 AM AEDT| By Team Kalkine MediaHighlights,Principal Financial Group Inc. expanded its holdings in Varex Imaging, contributing to increased institutional participation.,Multiple financial firms adjusted their positions in the company, reflecting shifts in market engagement.,Varex I...
